Posay's Effaclar collection is the gold standard. Beloved for its lightweight textures, efficacious ingredients and friendly price point, it's no wonder the range is one of the brand's bestsellers. So ...

The American Association for Cancer Research’s annual conference is in full swing, with Boehringer Ingelheim, Merck, GSK, Roche and more presenting new data for oncology cornerstones and ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial-intelligence-powered analysis to provide what the company says could ...

All linked products are independently selected by our editors. If you purchase any of these products, we may earn a commission. But all this immense social media hype isn’t merely skin deep.

If you missed the last La Roche-Posay sale at Ulta, you’re in luck: Today, the brand’s popular SPF 50 sunscreen is on sale as part of Ulta’s Buy More Save More sale, with discounts on all ...

Pharmaceutical giant Roche may have made profits more than a hundred times what it cost the company to bring a rare-disease drug to the Indian market, The Times of India reported on April 28. The drug ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug ...